Company Filing History:
Years Active: 2024
Title: Dmitri Bobilev: Innovator in Cancer Treatment
Introduction
Dmitri Bobilev is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on methods that utilize anti-TIM-3 antibodies to combat cancer effectively.
Latest Patents
Dmitri Bobilev holds 1 patent for his invention titled "Methods of treating cancer with anti-TIM-3 antibodies." This patent outlines methods for administering specific TIM-3 binding agents to patients diagnosed with cancer. The disclosure also includes detailed dosage regimens for compositions that comprise a TIM-3 binding agent, showcasing his commitment to advancing cancer therapies.
Career Highlights
Bobilev is currently employed at Tesaro, Inc., a company dedicated to developing innovative cancer therapies. His role at Tesaro allows him to collaborate with other experts in the field and contribute to groundbreaking research that aims to improve patient outcomes.
Collaborations
Dmitri has worked alongside talented colleagues, including Andrew R. Ferguson and Kristen Anne McEachern. Their collaborative efforts have been instrumental in advancing the research and development of cancer treatment methodologies.
Conclusion
Dmitri Bobilev's work in cancer treatment exemplifies the impact of innovative thinking in the medical field. His patent on anti-TIM-3 antibodies represents a significant step forward in the fight against cancer.